Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
Abstract Introduction Several studies have investigated the efficacy of human urinary kallidinogenase (HUK) combined with edaravone (Eda) in acute ischemic stroke (AIS) patients. Our aim was to provide the best available evidence for clinical practice and further research programs for stroke treatme...
Main Authors: | Di‐Xiao Yang, Yao Li, Dan Yu, Bi Guan, Qian Ming, Yan Li, Li‐Qing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2431 |
Similar Items
-
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
by: Yun Qian, et al.
Published: (2019-12-01) -
Cost-effectiveness of edaravone dexborneol versus human urinary kallidinogenase for acute ischemic stroke in China
by: Pingyu Chen, et al.
Published: (2024-01-01) -
Human urinary kallidinogenase decreases the incidence of post-stroke cognitive impairment in acute ischemic stroke patients
by: Xu Yan, et al.
Published: (2022-04-01) -
Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
by: Zhenyu Wei, et al.
Published: (2018-06-01) -
Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke
by: Juexian Song, et al.
Published: (2018-02-01)